Cream Recall: Wisconsin Pharmacal MG217
Announced 2026-05-27 · FDA
The FDA is recalling 690 tubes of MG217 Multi-Symptom Treatment Cream & Skin Protectant due to confirmed microbial contamination with Staphylococcus aureus in non-sterile products. The recall covers products distributed nationwide in the United States and in the Bahamas; Lot 1024088 with expiration date 11/30/2026 is identified among affected lots. No corrective action is provided in the available information.
| Brand | Wisconsin Pharmacal Company |
|---|---|
| Product | MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037. |
| Reason | Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus. |
| Severity | critical |
| Units affected | 690 |
| Distribution | USA Nationwide and Bahamas |
| Agency | FDA |
| Recall / campaign no. | Lot #: 1024088, Exp 11/30/2026 |
WHAT YOU SHOULD DO
- Stop using the product and discard any affected tubes.
- Check the tube for Lot number 1024088 to determine if yours is affected.
- Contact Wisconsin Pharmacal or the place of purchase for refund or replacement instructions.
- If you have experienced symptoms, consult a healthcare professional and consider reporting adverse events to your local health authority.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.